Influenza A virus subtype H1N1

Anxiety, Depression, Insomnia: New Study Reveals COVID-19 is Having an Impact on Americans' Mental Health

Friday, April 3, 2020 - 3:02pm

Eight in ten (81%) think the pandemic will have a negative impact on the mental health of Americans.

Key Points: 
  • Eight in ten (81%) think the pandemic will have a negative impact on the mental health of Americans.
  • 57% of those who either personally or had an immediate family member access mental health care during the pandemic said it was difficult to access mental health care.
  • Seven in ten (71%) agree that the availability of telehealth mental health care services would make them more likely to seek mental health care if they felt they needed it.
  • 57% of those who either personally or had an immediate family member access mental health care during the pandemic said it was difficult to access mental health care during the pandemic.

New Study of Americans At Risk for Severe COVID-19 Illness Shows More than a Quarter Lack Access to Adequate Intensive Care Resources

Friday, April 3, 2020 - 3:19pm

The study found that more than a quarter28.4 percentof high-risk Americans would likely have challenges accessing critical care resources during the COVID-19 pandemic.

Key Points: 
  • The study found that more than a quarter28.4 percentof high-risk Americans would likely have challenges accessing critical care resources during the COVID-19 pandemic.
  • "We know people at-risk for severe illnesses are dispersed across the U.S., and we know that ICU beds and ventilators are in short supply.
  • This study allows us to project areas of highest need as the pandemic evolves," said Maeve O'Meara, CEO of Castlight Health.
  • We guide individualsbased on their unique profileto the best resources available to them, whether they are healthy, chronically ill, or actively seeking medical care.

Tencent Open-sources Another AI-powered Tool to Help Conduct Preliminary Self-evaluation Regarding COVID-19 Infection

Friday, April 3, 2020 - 3:00pm

The COVID-19 self-triage assistant, which is now available on Github for developers around the world, enables preliminary self-evaluation regarding infection of the disease and provides tips on its prevention.

Key Points: 
  • The COVID-19 self-triage assistant, which is now available on Github for developers around the world, enables preliminary self-evaluation regarding infection of the disease and provides tips on its prevention.
  • Prior to this tool, Tencent open-sourced a COVID-19 live updates module last Friday that has answered six billion pandemic-related queries in China over the past two months.
  • By translating professional medical guidance into easy-to-understand messages, this tool was designed to help the public fight the pandemic with knowledge and skills.
  • The tool seeks to help users with symptoms such as fevers and coughing to conduct a preliminary self-evaluation of their illnesses quickly and seek medical care appropriately.

Quad Provides Business Update Related to COVID-19

Thursday, April 2, 2020 - 11:02pm

Quad/Graphics, Inc. (NYSE: QUAD) (Quad or the Company) today provided a business update on its actions taken in response to the COVID-19 pandemic.

Key Points: 
  • Quad/Graphics, Inc. (NYSE: QUAD) (Quad or the Company) today provided a business update on its actions taken in response to the COVID-19 pandemic.
  • We will continue to prioritize the health and well-being of our employees while making the tough but necessary decisions to protect the financial health of Quad.
  • Given the uncertainty of the duration of the COVID-19 pandemic, Quad is withdrawing its full-year 2020 financial guidance issued on February 18, 2020.
  • Quad has multiple locations throughout North America, South America and Europe, and strategic partnerships in Asia and other parts of the world.

Ending Pandemics Calls for Broad U.S. Public Participation in New COVID-19 Tracking Program

Thursday, April 2, 2020 - 4:00pm

COVID Near You was released today for public participation at www.covidnearyou.org .

Key Points: 
  • COVID Near You was released today for public participation at www.covidnearyou.org .
  • MPH, president of Ending Pandemics and co-creator of Flu Near You, said: "Many people have expressed feelings of powerlessness in the face of this COVID-19 pandemic.
  • "We are excited to see the growing interest in direct community engagement for pandemics preparedness and response," said Dr. Smolinski.
  • Founded in 2010 within the Skoll Global Threats Fund, San Francisco-based Ending Pandemics was spun out as an independent nonprofit organization in 2018.

MichBusiness offers support services, resources to state's small businesses during COVID-19 pandemic

Thursday, April 2, 2020 - 2:05pm

WARREN, Mich., April 2, 2020 /PRNewswire/ -- MichBusiness has been supporting small businesses throughout the state of Michigan for over 30 years.

Key Points: 
  • WARREN, Mich., April 2, 2020 /PRNewswire/ -- MichBusiness has been supporting small businesses throughout the state of Michigan for over 30 years.
  • As the business landscape and guidelines change during the COVID-19 pandemic, they are providing new resources and support daily to the entire business community in partnership with their sister brand Corp!
  • The MichBusiness team is available during pandemic developments as they occur and will continue to inform the business community about its effects on small business.
  • MichBusiness (Michigan Business and Professional Association) helps small businesses across Michigan succeed through valuable resources, educational programs, high-impact events and more.

UW–Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine

Thursday, April 2, 2020 - 5:15pm

Kawaokas lab will insert gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19, into M2SR so that the new vaccine will also induce immunity against the coronavirus.

Key Points: 
  • Kawaokas lab will insert gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19, into M2SR so that the new vaccine will also induce immunity against the coronavirus.
  • Bharat Biotech in Hyderabad, India will then begin production scale-up for safety and efficacy testing in humans.
  • Bharat Biotech has commercialized 16 vaccines, including a vaccine developed against the H1N1 flu that caused the 2009 pandemic.
  • Bharat Biotech will manufacture the vaccine, conduct clinical trials and prepare to produce the vaccine for global distribution.

Nearly Half of Americans Say They've Already Lost Income as a Result of COVID-19; One-Third Anticipate Needing Additional Education or Training

Thursday, April 2, 2020 - 2:01pm

"Nearly half of all Americans already are reporting financial impacts as a result of the pandemic," said Dave Clayton, Senior Vice President, Consumer Insights at Strada Education Network.

Key Points: 
  • "Nearly half of all Americans already are reporting financial impacts as a result of the pandemic," said Dave Clayton, Senior Vice President, Consumer Insights at Strada Education Network.
  • For example, we're hearing that one in three respondents say if they lost their job due to COVID-19, they would need additional education or training to obtain a comparable job."
  • More than half of Americans are worried about losing their job as a result of the COVID-19 pandemic.
  • One-third of individuals surveyed think that if they lost their job, they would need additional education and training to get a comparable job.

University Hospital Basel, Switzerland Transfuses First Two COVID-19 Patients With INTERCEPT Treated Coronavirus Convalescent Plasma

Thursday, April 2, 2020 - 1:30pm

Cerus Corporation (Nasdaq: CERS) announced today that the University Hospital Basel transfused the first two COVID-19 patients with INTERCEPT treated coronavirus convalescent plasma (CCP).

Key Points: 
  • Cerus Corporation (Nasdaq: CERS) announced today that the University Hospital Basel transfused the first two COVID-19 patients with INTERCEPT treated coronavirus convalescent plasma (CCP).
  • Plasma collected from individuals who have recovered from coronavirus disease contains antibodies against the virus that may help fight the infection.
  • Based on WHO data, plasma collected from recovered COVID-19 patients contains antibodies that neutralize SARS-CoV-2 infectivity and may improve a patients ability to fight COVID-19.
  • Convalescent plasma has been cited as a potential therapy for viral infection dating back to the 1918 Spanish influenza A (H1N1) pandemic.

Cerus Corporation Announces the Inclusion of Pathogen Reduction Technology in the ISBT Working Party Recommendations for the Preparation of COVID-19 Convalescent Plasma

Thursday, April 2, 2020 - 1:30pm

Cerus Corporation (Nasdaq: CERS) announced today that the International Society of Blood Transfusion (ISBT) Working Party on Global Blood Safety issued a new document titled Points to consider in the preparation and transfusion of COVID-19 convalescent plasma.

Key Points: 
  • Cerus Corporation (Nasdaq: CERS) announced today that the International Society of Blood Transfusion (ISBT) Working Party on Global Blood Safety issued a new document titled Points to consider in the preparation and transfusion of COVID-19 convalescent plasma.
  • Convalescent plasma has emerged as a promising potential therapeutic to treat acutely ill COVID-19 patients, said Dr. Laurence Corash, Cerus chief scientific officer.
  • These just issued recommendations by the ISBT Working Party on Global Blood Safety provide a framework for institutions involved in collecting, manufacturing, and transfusing COVID-19 convalescent plasma.
  • Convalescent plasma has been cited as a potential therapy for viral infection dating back to the 1918 Spanish influenza A (H1N1) pandemic.